Ligand validation:8GDV

IHP: INOSITOL HEXAKISPHOSPHATE

IHP is a Ligand Of Interest in 8GDV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8GDV_IHP_A_302	1%	36%	0.452	0.559	1.6	0.93	6	2	1	0	100%	0.71
8GDV_IHP_A_301	1%	33%	0.454	0.558	1.66	1	6	5	1	0	100%	0.79
6ES8_IHP_A_501	36%	12%	0.184	0.875	1.45	2.56	5	15	15	0	100%	16
7E1J_IHP_C_201	27%	9%	0.137	0.781	2.2	2.23	10	9	0	0	100%	0.5
7SNQ_IHP_G_301	24%	53%	0.17	0.796	1.25	0.57	-	-	0	0	100%	1
6BHR_IHP_G_401	20%	48%	0.236	0.835	1.15	0.87	4	3	4	0	100%	16
7E1K_IHP_A_201	5%	5%	0.301	0.712	2.85	2.51	10	16	0	0	100%	1
1ZY7_IHP_A_901	99%	47%	0.055	0.989	1.01	1.03	2	3	2	0	100%	1
9D5J_IHP_A_801	99%	52%	0.047	0.976	0.97	0.89	3	1	4	0	100%	1
8YJC_IHP_A_3802	98%	45%	0.063	0.986	1.36	0.8	5	1	0	0	100%	1
3HO6_IHP_A_270	97%	24%	0.072	0.985	2.14	1	15	3	0	0	100%	1
9D5K_IHP_A_801	96%	41%	0.055	0.962	0.77	1.51	1	11	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.